Zota Health Care Limited Stock

Equities

ZOTA

INE358U01012

Pharmaceuticals

Market Closed - NSE India S.E. 09:03:24 2024-04-25 am EDT 5-day change 1st Jan Change
486.4 INR -1.24% Intraday chart for Zota Health Care Limited +0.03% +2.95%
Sales 2022 1.31B 15.77M Sales 2023 1.41B 16.91M Capitalization 7.09B 85.15M
Net income 2022 89M 1.07M Net income 2023 -57M -685K EV / Sales 2022 5.8 x
Net Debt 2022 126M 1.51M Net Debt 2023 440M 5.29M EV / Sales 2023 5.35 x
P/E ratio 2022
83.1 x
P/E ratio 2023
-123 x
Employees 338
Yield 2022
0.5%
Yield 2023
0.35%
Free-Float 93.9%
More Fundamentals * Assessed data
Dynamic Chart
Zota Health Care Limited Announces Resignation of Manukant Chandulal Zota as Whole-Time Director, Effective March 31, 2024 CI
Zota Health Care Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Zota Health Care Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Zota Health Care Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023 CI
Zota Health Care Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Zota Health Care Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Zota Health Care Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022 CI
Zota Health Care Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Zota Health Care Limited Reports Earnings Results for the Full Year Ended March 31, 2022 CI
Zota Health Care Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022 CI
Zota Health Care Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
Zota Health Care Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021 CI
Zota Health Care Limited Recommends Final Dividend for the Financial Year 2020-21 CI
Zota Health Care Limited Receives Product Registration Licenses for Ten Products from Turkmenistan CI
Zota Health Care Limited Proposes Declaration of Final Dividend for the Financial Year 2020-21 CI
More news
1 day-1.24%
1 week+0.03%
Current month+2.51%
1 month+1.70%
3 months-1.29%
6 months+21.16%
Current year+2.95%
More quotes
1 week
481.75
Extreme 481.75
495.35
1 month
470.60
Extreme 470.6
522.00
Current year
447.65
Extreme 447.65
555.00
1 year
271.95
Extreme 271.95
555.00
3 years
146.10
Extreme 146.1
555.00
5 years
121.10
Extreme 121.1
555.00
10 years
103.57
Extreme 103.5714
555.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 48 23-01-15
Director of Finance/CFO 48 14-09-29
Compliance Officer 33 15-08-31
Members of the board TitleAgeSince
Founder 57 94-12-31
Director/Board Member 49 00-07-11
Director/Board Member 51 00-07-11
More insiders
Date Price Change Volume
24-04-25 486.4 -1.24% 6,971
24-04-24 492.5 +1.43% 10,611
24-04-23 485.6 +0.41% 18,170
24-04-22 483.6 +0.43% 6,502
24-04-19 481.5 -0.98% 17,611

Delayed Quote NSE India S.E., April 25, 2024 at 09:03 am EDT

More quotes
Zota Health Care Limited is an India-based drug development, manufacturing and marketing company. The Company manufactures, markets, and exports pharmaceutical, ayurvedic, nutraceutical, and over the counter (OTC) products. The Company’s business model comprises three verticals, namely Domestic, Exports and Retail Pharmacy Chain (Davaindia). Its Marketing business vertical involves the direct distribution of generic drugs, OTC products, and other pharmaceutical products through the Company’s distribution network across India. It has a portfolio of more than 3,000 products in various categories, such as generics, OTC products, allopathic, ayurvedic and others. In the Retail Pharmacy Chain business vertical, it operates a chain of pharmacy stores under the brand Davaindia. Its domestic products include AMLOTOZ AT Tab, APIXACEED 2.5 Tab, APIXACEED 5 Tab, ATRONA 10 Tab, ATRONA 20 Tab, ATRONA 40 Tab, ATRONA ASP 75 Cap, ATRONA ASP 150 Cap, ATRONA ASP 20/75 Cap, ATRONA FB Tab and others.
More about the company